Epidemiology and outcomes of community-acquired clostridium difficile infections in medicare beneficiaries

Journal of the American College of Surgeons

Volumn 218, Issue 6, 2014, Pages 1141-1147.e1

  Collins, Courtney E ^a   Ayturk, M Didem ^a   Flahive, Julie M ^a   Emhoff, Timothy A ^a   Anderson, Frederick A ^a   Santry, Heena P ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; PENICILLIN DERIVATIVE; PRESCRIPTION DRUG; STOMACH SECRETION INHIBITOR; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; COMMUNITY ACQUIRED CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY ACQUIRED INFECTION; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; GROUPS BY AGE; HEALTH CARE SYSTEM; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; INFECTION PREVENTION; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MEDICARE; TREATMENT OUTCOME; UNITED STATES;

EID: 84901244988     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2014.01.053     Document Type: Article

References (38)

1. J. Pepin, L. Valiquette, and M.E. Alary et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity CMAJ 171 2004 466 472
2. F.C. Lessa, C.V. Gould, and L.C. McDonald Current status of Clostridium difficile infection epidemiology Clin Infect Dis 55 Suppl 2 2012 S65 S70
3. B.A. Miller, L.F. Chen, D.J. Sexton, and D.J. Anderson Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals Inf Control Hosp Epidemiol 32 2011 387 390
4. Department of Health and Human Services, Administration on Aging. Aging statistics. Projected future growth of the older population. By age: 1900-2050. Persons 65 and older. Available at: http://www.aoa.gov/Aging-Statistics/future- growth/future-growth.aspx. Accessed March 6, 2014.
5. M.D. Redelings, F. Sorvillo, and L. Mascola Increase in Clostridium difficile-related mortality rates, United States, 1999-2004 Emerg Inf Dis 13 2007 1417 1419
6. R. Ricciardi, D.A. Rothenberger, R.D. Madoff, and N.N. Baxter Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States Arch Surg 142 2007 624 631 discussion 631
7. J.R. Zahar, C. Schwebel, and C. Adrie et al. Outcome of ICU patients with Clostridium difficile infection Crit Care 16 2012 R215
8. L. Beaugerie, A. Flahault, and F. Barbut et al. Antibiotic-associated diarrhoea and Clostridium difficile in the community Aliment Pharmacol Ther 17 2003 905 912
9. M.H. Wilcox, L. Mooney, and R. Bendall et al. A case-control study of community-associated Clostridium difficile infection J Antimicrob Chemother 62 2008 388 396
10. P.K. Kutty, C.W. Woods, and A.C. Sena et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina USA. Emerg Infect Dis 16 2010 197 204
11. S. Khanna, D.S. Pardi, and S.L. Aronson et al. Outcomes in community-acquired Clostridium difficile infection Aliment Pharmacol Ther 35 2012 613 618
12. S. Khanna, D.S. Pardi, and S.L. Aronson et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study American J Gastroenterol 107 2012 89 95
13. A.S. Chitnis, S.M. Holzbauer, and R.M. Belflower et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011 JAMA Int Med 173 2013 1359 1367
14. A. Elixhauser, C. Steiner, D.R. Harris, and R.M. Coffey Comorbidity measures for use with administrative data Med Care 36 1998 8 27
15. M. Zerey, B.L. Paton, and A.E. Lincourt et al. The burden of Clostridium difficile in surgical patients in the United States Surg Inf 8 2007 557 566
16. S. Naggie, B.A. Miller, and K.B. Zuzak et al. A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors Am J Med 124 2011 276.e1 276.e7
17. J. Pepin, N. Saheb, and M.A. Coulombe et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec Clin Infect Dis 41 2005 1254 1260
18. S. Dial, J.A. Delaney, A.N. Barkun, and S. Suissa Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease JAMA 294 2005 2989 2995
19. G.E. Bignardi Risk factors for Clostridium difficile infection J Hosp Inf 40 1998 1 15
20. F. Barbut, and J.C. Petit Epidemiology of Clostridium difficile-associated infections Clin Microbiol Inf 7 2001 405 410
21. S. Dial, A. Kezouh, and A. Dascal et al. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection CMAJ 179 2008 767 772
22. J.L. Kuntz, E.A. Chrischilles, and J.F. Pendergast et al. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study BMC Inf Dis 11 2011 194
23. C.A. Muto, M. Pokrywka, and K. Shutt et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use Inf Control Hosp Epidemiol 26 2005 273 280
24. J. Pepin, M.E. Alary, and L. Valiquette et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada Clin Inf Dis 40 2005 1591 1597
25. A. Deshpande, V. Pasupuleti, and P. Thota et al. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis J Antimicrob Chemother 68 2013 1951 1961
26. K.A. Brown, N. Khanafer, N. Daneman, and D.N. Fisman Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection Antimicrob Agent Chemother 57 2013 2326 2332
27. M.P. Hensgens, A. Goorhuis, O.M. Dekkers, and E.J. Kuijper Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics J Antimicrob Chemother 67 2012 742 748
28. D.M. Musher, S. Aslam, and N. Logan et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole Clin Infect Dis 40 2005 1586 1590
29. L.A. Petrella, S.P. Sambol, and A. Cheknis et al. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain Clin Infect Dis 55 2012 351 357
30. S. Dial, J.A. Delaney, V. Schneider, and S. Suissa Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy CMAJ 175 2006 745 748
31. A. Deshpande, C. Pant, and V. Pasupuleti et al. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis Clin Gastroenterol Hepatol 10 2012 225 233
32. S. Khanna, S.L. Aronson, and P.P. Kammer et al. Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study Mayo Clin Proc 87 2012 636 642
33. A.M. Kasper, H.A. Nyazee, and D.S. Yokoe et al. A multicenter study of Clostridium difficile infection-related colectomy, 2000-2006 Inf Control Hosp Epidemiol 33 2012 470 476
34. A.J. Klobuka, and A. Markelov Current status of surgical treatment for fulminant clostridium difficile colitis World J Gastrointest Surg 5 2013 167 172
35. S. Johnson Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes J Infect 58 2009 403 410
36. D.W. Eyre, A.S. Walker, and D. Wyllie et al. Predictors of first recurrence of Clostridium difficile infection: implications for initial management Clin Infect Dis 55 Suppl 2 2012 S77 S87
37. C.P. Kelly, and J.T. LaMont Clostridium difficile-more difficult than ever N Engl J Med 359 2008 1932 1940
38. Medicare Payment Advisory Commission A Data Book: Medicare Part D Program 2010 Medicare Payment Advisory Commission Washington, DC